EP1992338A3 - Pharmaceutical compositions for the oral administration of heparin or derivatives thereof - Google Patents
Pharmaceutical compositions for the oral administration of heparin or derivatives thereof Download PDFInfo
- Publication number
- EP1992338A3 EP1992338A3 EP08160486A EP08160486A EP1992338A3 EP 1992338 A3 EP1992338 A3 EP 1992338A3 EP 08160486 A EP08160486 A EP 08160486A EP 08160486 A EP08160486 A EP 08160486A EP 1992338 A3 EP1992338 A3 EP 1992338A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- pharmaceutical compositions
- oral administration
- heparin
- derivatives
- parnaparin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001MI002599A ITMI20012599A1 (en) | 2001-12-11 | 2001-12-11 | PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF HEPARINE OR DERIVATIVES, USEFUL FOR THERAPY OF INFLAMMATORY DISEASES OF THE INT |
EP02791763A EP1455761B1 (en) | 2001-12-11 | 2002-12-03 | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02791763.2 Division | 2002-12-03 | ||
EP02791763A Division EP1455761B1 (en) | 2001-12-11 | 2002-12-03 | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1992338A2 EP1992338A2 (en) | 2008-11-19 |
EP1992338A3 true EP1992338A3 (en) | 2009-08-12 |
EP1992338B1 EP1992338B1 (en) | 2012-06-27 |
Family
ID=11448679
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08160486A Expired - Lifetime EP1992338B1 (en) | 2001-12-11 | 2002-12-03 | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
EP02791763A Expired - Lifetime EP1455761B1 (en) | 2001-12-11 | 2002-12-03 | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02791763A Expired - Lifetime EP1455761B1 (en) | 2001-12-11 | 2002-12-03 | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
Country Status (18)
Country | Link |
---|---|
US (1) | US8642082B2 (en) |
EP (2) | EP1992338B1 (en) |
JP (1) | JP4634713B2 (en) |
KR (2) | KR100984801B1 (en) |
CN (2) | CN100490823C (en) |
AT (1) | ATE410148T1 (en) |
AU (1) | AU2002358082A1 (en) |
CA (1) | CA2465832C (en) |
CY (1) | CY1108625T1 (en) |
DE (1) | DE60229287D1 (en) |
DK (2) | DK1992338T5 (en) |
ES (2) | ES2312652T3 (en) |
HK (1) | HK1072181A1 (en) |
IT (1) | ITMI20012599A1 (en) |
MX (1) | MXPA04005710A (en) |
PT (2) | PT1455761E (en) |
SI (1) | SI1455761T1 (en) |
WO (1) | WO2003049721A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
DK1183014T3 (en) | 1999-06-14 | 2004-02-09 | Cosmo Spa | Flavored controlled release oral pharmaceutical compositions |
EP2060253A1 (en) | 2007-11-14 | 2009-05-20 | Laboratorios Farmaceuticos Rovi, S.A. | Pharmaceutical forms for the release of active compounds |
US8257744B2 (en) * | 2000-07-07 | 2012-09-04 | Laboratorios Farmacéuticos Rovi, S.A. | Pharmaceutical forms for the release of active compounds |
SE0201922D0 (en) | 2002-06-20 | 2002-06-20 | Ltp Lipid Technologies Provide | Anticoagulant Composition |
EP1792621B1 (en) | 2005-11-30 | 2012-04-04 | Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" | Orally administrable heparin derivatives |
RU2009113557A (en) * | 2006-09-12 | 2010-10-20 | Космо Текнолоджиз Лтд (Ie) | PHARMACEUTICAL COMPOSITIONS FOR ORAL OR RECTAL INTRODUCTION OF PROTEIN SUBSTANCES |
KR100837558B1 (en) | 2007-04-30 | 2008-06-12 | (주)아모레퍼시픽 | Emulsion composition containing double-stabilized ceramide nano capsule, method for manufacturing the same, and cosmetic composition containing the same |
EP2213282A1 (en) | 2009-01-30 | 2010-08-04 | Laboratorios Farmaceuticos Rovi, S.A. | Pharmaceutical forms for the release of active compounds |
US8802156B2 (en) | 2007-11-14 | 2014-08-12 | Laboratorios Farmacéuticos Rovi, S.A. | Pharmaceutical forms for the release of active compounds |
KR101291813B1 (en) | 2011-04-27 | 2013-08-02 | 임승택 | Dextrin-ceramide complex with increased hydrophilicity and preparing method thereof |
US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
KR20200037574A (en) | 2018-10-01 | 2020-04-09 | (주)우리비앤비 | Cosmetic composition for preventing hair loss comprising heparin |
EP3791884A1 (en) * | 2019-09-16 | 2021-03-17 | Oskar Bunz | Combination of heparin and magnesium salt for the treatment of viral infections |
CN110585164A (en) * | 2019-10-08 | 2019-12-20 | 苏州弘森药业股份有限公司 | Method for preparing esomeprazole magnesium sodium bicarbonate capsule |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000048589A1 (en) * | 1999-02-22 | 2000-08-24 | Emisphere Holdings, Inc. | Solid oral dosage form containing heparin or a heparinoid in combination with a carrier |
WO2000076481A1 (en) * | 1999-06-14 | 2000-12-21 | Cosmo S.P.A. | Mesalazine controlled release oral pharmaceutical compositions |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6054313A (en) | 1983-09-01 | 1985-03-28 | Terumo Corp | Heparin composition absorbable through intestine |
JP2893191B2 (en) * | 1988-11-08 | 1999-05-17 | 武田薬品工業株式会社 | Controlled release matrix agent |
IE61651B1 (en) | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
US5665379A (en) * | 1990-09-28 | 1997-09-09 | Pharmacia & Upjohn Aktiebolag | Lipid particle forming matrix, preparation and use thereof |
DE69425453T2 (en) | 1993-04-23 | 2001-04-12 | Novartis Ag | Drug delivery device with controlled release |
US5665370A (en) * | 1995-02-22 | 1997-09-09 | Temple University Of The Commonwealth System Of Higher Education | Compositions containing cockroach aggregation pheromones, their production and uses |
FR2763848B1 (en) * | 1997-05-28 | 2000-01-28 | Rhone Poulenc Rorer Sa | USE OF LOW MOLECULAR WEIGHT HEPARINS FOR THE PREVENTION AND TREATMENT OF CENTRAL NERVOUS TRAUMA |
IT1298575B1 (en) * | 1998-02-06 | 2000-01-12 | Vectorpharma Int | PHARMACEUTICAL COMPOSITIONS IN THE FORM OF NANOPARTICLES INCLUDING LIPID SUBSTANCES AND ANTIPHILIC SUBSTANCES AND RELATED PROCESS OF |
US6423345B2 (en) * | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
MXPA02004741A (en) | 1999-11-12 | 2003-12-11 | Emisphere Tech Inc | Liquid heparin formulation. |
EP1390383B1 (en) * | 2001-05-11 | 2012-02-29 | Isis Pharmaceuticals, Inc. | Antisense permeation enhancers |
-
2001
- 2001-12-11 IT IT2001MI002599A patent/ITMI20012599A1/en unknown
-
2002
- 2002-12-03 JP JP2003550770A patent/JP4634713B2/en not_active Expired - Fee Related
- 2002-12-03 ES ES02791763T patent/ES2312652T3/en not_active Expired - Lifetime
- 2002-12-03 CN CNB2006100733879A patent/CN100490823C/en not_active Expired - Fee Related
- 2002-12-03 DK DK08160486.0T patent/DK1992338T5/en active
- 2002-12-03 EP EP08160486A patent/EP1992338B1/en not_active Expired - Lifetime
- 2002-12-03 KR KR1020047008910A patent/KR100984801B1/en not_active IP Right Cessation
- 2002-12-03 MX MXPA04005710A patent/MXPA04005710A/en active IP Right Grant
- 2002-12-03 CA CA2465832A patent/CA2465832C/en not_active Expired - Fee Related
- 2002-12-03 PT PT02791763T patent/PT1455761E/en unknown
- 2002-12-03 AU AU2002358082A patent/AU2002358082A1/en not_active Abandoned
- 2002-12-03 CN CNB028240812A patent/CN1258360C/en not_active Expired - Fee Related
- 2002-12-03 US US10/498,095 patent/US8642082B2/en not_active Expired - Fee Related
- 2002-12-03 KR KR1020097011163A patent/KR101062687B1/en not_active IP Right Cessation
- 2002-12-03 DE DE60229287T patent/DE60229287D1/en not_active Expired - Lifetime
- 2002-12-03 SI SI200230768T patent/SI1455761T1/en unknown
- 2002-12-03 ES ES08160486T patent/ES2386922T3/en not_active Expired - Lifetime
- 2002-12-03 WO PCT/EP2002/013651 patent/WO2003049721A1/en active Application Filing
- 2002-12-03 AT AT02791763T patent/ATE410148T1/en active
- 2002-12-03 EP EP02791763A patent/EP1455761B1/en not_active Expired - Lifetime
- 2002-12-03 DK DK02791763T patent/DK1455761T3/en active
- 2002-12-03 PT PT08160486T patent/PT1992338E/en unknown
-
2005
- 2005-03-15 HK HK05102284.6A patent/HK1072181A1/en not_active IP Right Cessation
-
2008
- 2008-12-08 CY CY20081101416T patent/CY1108625T1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000048589A1 (en) * | 1999-02-22 | 2000-08-24 | Emisphere Holdings, Inc. | Solid oral dosage form containing heparin or a heparinoid in combination with a carrier |
WO2000076481A1 (en) * | 1999-06-14 | 2000-12-21 | Cosmo S.P.A. | Mesalazine controlled release oral pharmaceutical compositions |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1072181A1 (en) | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof | |
WO2003053368A3 (en) | Chalcone derivatives and their use to treat diseases | |
WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
AU2003268156A1 (en) | Novel pyrazolopyridine derivatves as pharmaceutical agents | |
MXPA03002814A (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases. | |
WO2003080582A3 (en) | Fredericamycin derivatives | |
NO20042739L (en) | Pharmaceutical compositions of 5,6,14-triazatetracyclo (10.3.1.0 (2,11) .0 (4.9)) - hexadeca-2 (11) 3,5,7,9-pentane | |
IL161623A (en) | Nicotin-or isonicotin benzothiazole derivatives, their preparation and pharmaceutical compositions comprising them | |
PL367682A1 (en) | Dolastatin 10 derivatives | |
HK1128679A1 (en) | 1,2-diphenylethene derivatives for treatment of immune diseases 12- | |
MXPA03010761A (en) | Pharmaceutical combinations. | |
HUP0300848A2 (en) | A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer | |
WO2002087596A3 (en) | Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases | |
NO20024662D0 (en) | Prodrugs of imidazopyridine derivatives | |
NO20054346L (en) | Compositions and methods for the prevention and treatment of endotoxin-related diseases and conditions | |
ATE286894T1 (en) | 2H-1-BENZOPYRAN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS | |
WO2003051838A3 (en) | Protein kinase inhibitors | |
NO20031410L (en) | Use of distamycin derivatives for the manufacture of drugs | |
AU2002325169A1 (en) | Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases | |
MY139613A (en) | Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
HK1065305A1 (en) | Substituted 4-aminocyclohexanol derivatives | |
HUP0400925A3 (en) | Azolycarbynol derivatives of aryl (or heteroaryl) for producing pharmaceutical compositions for the treatment of respiratory diseases | |
HUP0402654A2 (en) | 2-[(2'-halo-3',5'-dialkoxyphenyl)-imino]-imidazolidine derivatives, use thereof and pharmaceutical compositions containing them | |
ATE286893T1 (en) | 2H-1-BENZOPYRAN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 1455761 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: AJANI, MAURO Inventor name: MORO, LUIGI Inventor name: VILLA, ROBERTO |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1124235 Country of ref document: HK |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR |
|
17P | Request for examination filed |
Effective date: 20091112 |
|
AKX | Designation fees paid |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: COSMO TECHNOLOGIES LTD |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 1455761 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 563747 Country of ref document: AT Kind code of ref document: T Effective date: 20120715 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20120724 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 60243242 Country of ref document: DE Effective date: 20120823 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2386922 Country of ref document: ES Kind code of ref document: T3 Effective date: 20120906 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: PATENTANWAELTE SCHAAD, BALASS, MENZL & PARTNER AG |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20120402064 Country of ref document: GR Effective date: 20120915 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T5 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20130328 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 60243242 Country of ref document: DE Effective date: 20130328 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121203 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1124235 Country of ref document: HK |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BG Payment date: 20151222 Year of fee payment: 14 Ref country code: GR Payment date: 20151230 Year of fee payment: 14 Ref country code: GB Payment date: 20151229 Year of fee payment: 14 Ref country code: CH Payment date: 20151228 Year of fee payment: 14 Ref country code: IE Payment date: 20151231 Year of fee payment: 14 Ref country code: DK Payment date: 20151228 Year of fee payment: 14 Ref country code: FI Payment date: 20151229 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20151119 Year of fee payment: 14 Ref country code: SE Payment date: 20151230 Year of fee payment: 14 Ref country code: FR Payment date: 20151217 Year of fee payment: 14 Ref country code: CZ Payment date: 20151124 Year of fee payment: 14 Ref country code: ES Payment date: 20151228 Year of fee payment: 14 Ref country code: PT Payment date: 20151120 Year of fee payment: 14 Ref country code: NL Payment date: 20151226 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20151229 Year of fee payment: 14 Ref country code: IT Payment date: 20151218 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20151228 Year of fee payment: 14 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161231 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60243242 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161203 Ref country code: CZ Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161203 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20170101 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 563747 Country of ref document: AT Kind code of ref document: T Effective date: 20161203 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20161203 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170605 Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161204 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170101 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20170831 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161231 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161203 Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161203 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170102 Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170707 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161203 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170701 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161203 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20151203 Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20161231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161204 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20161231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161231 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20181116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170808 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161203 |